Oprozomib in patients with newly diagnosed multiple myeloma. 2019

Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
Medical College of Wisconsin, Milwaukee, WI, USA. phari@mcw.edu.

UI MeSH Term Description Entries
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
June 2002, Current treatment options in oncology,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
November 2023, Alternative therapies in health and medicine,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
July 2020, Blood research,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
January 2003, Mayo Clinic proceedings,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
November 2015, Blood reviews,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
February 2007, Haematologica,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
November 2023, Clinical and experimental medicine,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
May 2019, Cureus,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
May 2019, Current oncology reports,
Parameswaran Hari, and Jeffrey V Matous, and Peter M Voorhees, and Kenneth H Shain, and Mihaela Obreja, and John Frye, and Hisaki Fujii, and Andrzej J Jakubowiak, and Davide Rossi, and Pieter Sonneveld
January 2016, Cancer treatment and research,
Copied contents to your clipboard!